---
title: 'Implementing precision oncology for sarcoma patients: the CCC<sup>LMU</sup>molecular
  tumor board experience'
date: '2023-08-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37542550/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230806180720&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Our single-center experience shows an increasing uptake
  of next-generation sequencing (NGS) and highlights current challenges of implementing
  precision oncology in the management of patients with BS/STS. A relevant number
  of patients were diagnosed with clinically actionable alterations. Our results highlight
  the potential benefit of NGS in patients with rare cancers and currently limited
  therapeutic ...'
disable_comments: true
---
CONCLUSION: Our single-center experience shows an increasing uptake of next-generation sequencing (NGS) and highlights current challenges of implementing precision oncology in the management of patients with BS/STS. A relevant number of patients were diagnosed with clinically actionable alterations. Our results highlight the potential benefit of NGS in patients with rare cancers and currently limited therapeutic ...